Clinical and Translational Oncology

, Volume 7, Issue 5, pp 219–227 | Cite as

Embryonic tumours of the central nervous system

  • Aurora Navajas Gutiérrez
  • Ana Fernández-Teijeiro Álvarez
  • the CNS Tumours Working Group of the Spanish Society of Paediatric Oncology
Educational Review

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Giangaspero RJ, Perry RH, Kelly PJ, et al. In: Kleihues. P, Cavenee WK, editors. World Health Organization Classification of Tumours; Pathology and Genetics of Tumours of the Nervous System. Lyon. (France): International Agency for Research on Cancer IARC Press; 2000. p. 123–39.Google Scholar
  2. 2.
    Strother DR, Pollack IF, Fisher PG, et al. Tumors of the central nervous system. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. Philadelphia PA: Lippincott Williams and Wilkins; 2002. p. 751–824.Google Scholar
  3. 3.
    Kühl J, Doz F, Taylor R. En: Walker DA, Perilongo G, Punt JAG, Taylor RE, editors. Brain and spinal tumors of childhood Arnold. Oxford University Press Inc; 2004. p. 331–44.Google Scholar
  4. 4.
    Steliarova Foucher E, Stiller CH, Kaatssch, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet. 2004;364:2097–105.PubMedCrossRefGoogle Scholar
  5. 5.
    Peris Bonet R, Giner Ripoll B, García Cano A. Registro Nacional de Tumores Infantiles (RNTI-SEOP). Estadísticas básicas 4. 1980–2001, Supervivencia 1980–1997. Valencia, Universidad de Valencia: 2003.Google Scholar
  6. 6.
    Giangaspero F, Rigobello L, Bodily M, et al. Large cell medulloblastoma: A distinct variant with highly aggressive behavior. Am J Surg Pathol. 1992;16:687–93.PubMedCrossRefGoogle Scholar
  7. 7.
    Eberhart CG, Kepner JL, Goldthwait PT, et al. Histopathologic grading of medulloblastomas: A Pediatric Oncology Group Study. Cancer. 2002;94:552–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Eberhart CG, Burger PC. Anaplasia and grading in medulloblastomas: Brain Pathol. 2003;13:376–85.PubMedCrossRefGoogle Scholar
  9. 9.
    Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous System embryonal tumour outcome based on gene expression. Nature. 2002;415:436–42.PubMedCrossRefGoogle Scholar
  10. 10.
    Mulhern RK, Palmer SL, Reddick WE, et al. Risk of young age for selective neurocognitive deficits in medulloblastoma are associated with White matter loss. J Clin Oncol. 2001;19:472–9.PubMedGoogle Scholar
  11. 11.
    Carrie C, Hoffstetter S, Gomez F, et al. Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys. 1999;45:435–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Peet AC, Leach MO, Pinkerton CR, Price P, Williams SR, Grundy RG. Proceedings of the Engineering and Physical Sciences Research Council Workshop. The development of Functional imaging in the diagnosis, management and understanding of childhood brain tumours. Pediatr Blood Cancer. 2005;44:103–13.PubMedCrossRefGoogle Scholar
  13. 13.
    Chang CH, Housepian EM, Herbert C. An operative staging system and a megavoltage radiotherapeutic technique for cerebellar meduloblastoma. Radiology. 1969;93:1351–9.PubMedGoogle Scholar
  14. 14.
    Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastomas in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol. 1999;17:832–45.PubMedGoogle Scholar
  15. 15.
    Fernández-Teijeiro A, Betensky RA, Sturla LM, et al. Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas. J Clin Oncol. 2004;22:994–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Gajjar A, Hernan R, Kocak M, et al. Clinical, histopathological and molecular markers of prognosis: Towards a new disease risk stratification for medulloblastoma. J Clin Oncol. 2004;22:984–93.PubMedCrossRefGoogle Scholar
  17. 17.
    Gilbertson R, Wickramasinghe C, Hernan R, et al. Clinical and molecular stratification of disease risk in medulloblastoma. Brit J Cancer. 2001;85:705–12.PubMedCrossRefGoogle Scholar
  18. 18.
    Grotzer MA, Janss AJ, Fung K, et al. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol. 2000;18:1027–35.PubMedGoogle Scholar
  19. 19.
    Cvekl A Jr, Zavadil J, Birshtein BK, Grotzer MA, Cvekl A. Analysis of transcripts from 17p13.3 in medulloblastoma suggests ROX/MNT as a potential tumour suppressor gene. Eur J Cancer. 2004;40(16):2525–32.PubMedCrossRefGoogle Scholar
  20. 20.
    Taylor RE, Bailey CC, Robinson K, et al. Results of a randomised study of pre-radiotherapy chemotherapy vs radiotherapy alone for non-metastatic (M0–1) medulloblastoma. The SIOP/UKCCSG PNET-3 study. J Clin Oncol. 2003;21:1581–91.PubMedCrossRefGoogle Scholar
  21. 21.
    Packer RJ, Goldwein J, Nicholson HS, et al. Treatment of children with medulloblastomas with reduced dose craniospinal radiation therapy and adjuvant chemotherapy: a Children’s Cancer Group Study. J Clin Oncol. 1999;17:2127–36.PubMedGoogle Scholar
  22. 22.
    Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS. Outcome for children with medulloblastomas treated with radiation and cisplatin, CCNU and vincristine chemotherapy. J Neurosurg. 1994;81:690–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Grill J, Kieffer-Renaux V, Bulteau C, et al. Long term intellectual outcome in children with posterior fossa tumours according to radiation doses and volumes. Int J Radiat Oncol Biol Phys. 1999;45:137–45.PubMedCrossRefGoogle Scholar
  24. 24.
    Tait DM, Thornton-Jones H, Bollom HJG, et al. Adjuvant chemotherapy for medulloblastoma: The first multicentre control trial of the International Society of Pediatric Oncology (SIOP I). Eur J Cancer. 1990;26:464–9.PubMedGoogle Scholar
  25. 25.
    Ellison DW, Clifford SC, Gajjar A, et al. Recent advances in medulloblastoma. Eur J Ped Neurol. 2003;7:53–66.CrossRefGoogle Scholar
  26. 26.
    Kühl J. Modern treatment strategies in medulloblastoma. Childs Nerv Syst. 1998;14:2–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Kortmann RD, Kuhl J, Timmerman B, et al. Postoperative neoadjuvant chemotrerapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT’ 91. Int J Radiat Oncol Biol Phys. 2000;46:269–79.PubMedCrossRefGoogle Scholar
  28. 28.
    Rood BR, Macdonald TJ, Packer RJ. Current treatment of medulloblastoma: recent advances and future challenges. Semin Oncol. 2004;31(5):666–75.PubMedCrossRefGoogle Scholar
  29. 29.
    Blaney SM, Poplack DG, New cytotoxic drugs for intrathecal administration. J Neurooncol. 1998;38:219–23.PubMedCrossRefGoogle Scholar
  30. 30.
    Slavc I, Schuller E, Czech T, Hainfellner JA, Seidl R, Dieckmann K. Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination. J Neurooncol. 1998;38:213–8PubMedCrossRefGoogle Scholar
  31. 31.
    Miralbell R, Bieri S, Huguenin P, et al. Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma. Swis Pediatric Oncology Group. Ann Oncol. 1999;10:239–41.PubMedCrossRefGoogle Scholar
  32. 32.
    Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumours. N Engl J Med. 1993;328:1725–31.PubMedCrossRefGoogle Scholar
  33. 33.
    Duffner PK, Horowitz ME, Krischer JP, et al. The treatment of malignant brain tumours in infants and very young children: an update of the Pediatric Oncology Group experience. J Neuro Oncol. 1999;1:152–61.CrossRefGoogle Scholar
  34. 34.
    Palmer SL, Goloubeva O, Reddick WE, et al. Patterns of intellectual development among survivors of pediatric medulloblastoma. A longitudinal analysis. J Clin Oncol. 2001;19:2302–8.PubMedGoogle Scholar
  35. 35.
    Reddy AT, Janss AJ, Phillips PC, Weiss HL, Packer RJ. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation and chemotherapy. Cancer. 2000;88(9):2189–93.PubMedCrossRefGoogle Scholar
  36. 36.
    Timmerman B, Kortmann RD, Kühl, et al. The role of radiation therapy in the treatment of supratentorial PNET in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91. J Clin Oncol. 2002;20:842–9.CrossRefGoogle Scholar
  37. 37.
    Kalifa C, Valteau D, Pizer B, Vassal G, Grill J, Hartmann O. High dose chemotherapy in childhood brain tumours. Childs Nerv Syst. 1999;15:498–505.PubMedCrossRefGoogle Scholar
  38. 38.
    Pérez A, Quintero V, González M, et al High-dose chemotherapy with autologous stem cell rescue in children with high-risk and recurrent brain tumors. An Pediatr. 2004;61(1):8–15.CrossRefGoogle Scholar
  39. 39.
    Chi SN, Gardner SL, Levy AS, et al. Feasibility and response to induction chemotherapy intensified with highdose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol. 2004;22:4881–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Wolden SL, Dunkel IJ, Souweidane MM, et al. Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma. J Clin Oncol. 2003;21:3079–83.PubMedCrossRefGoogle Scholar
  41. 41.
    Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005;352:978–86.PubMedCrossRefGoogle Scholar
  42. 42.
    Gilbertson RJ. Medulloblastoma: signaling a change in treatment. Lancet Oncol. 2004;5(4):209–18.PubMedCrossRefGoogle Scholar

Copyright information

© FESEO 2005

Authors and Affiliations

  • Aurora Navajas Gutiérrez
    • 1
  • Ana Fernández-Teijeiro Álvarez
    • 1
  • the CNS Tumours Working Group of the Spanish Society of Paediatric Oncology
  1. 1.Unidad de Oncología PediátricaHospital de Cruces Vizcaya, University of the Basque CountrySpain

Personalised recommendations